{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:45:34Z","timestamp":1791164734065,"version":"4.1.0"},"reference-count":60,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0577","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:26Z","timestamp":1525238366000},"source":"Crossref","is-referenced-by-count":22,"title":["Hepatitis E in Germany"],"prefix":"10.3238","author":[{"given":"Sven","family":"Pischke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Thomas","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"key":"10.3238\/arztebl.2014.0577_ref1","doi-asserted-by":"crossref","unstructured":"Wedemeyer H, Pischke S, Manns MP: Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 2012; 142: 1388\u201397.","DOI":"10.1053\/j.gastro.2012.02.014"},{"key":"10.3238\/arztebl.2014.0577_ref2","unstructured":"Center for Disease Control and Prevention (CDC): Investigation of hepatitis E outbreak among refugees \u2013 Upper Nile, South Sudan, 2012\u20132013. MMWR Morb Mortal Wkly Rep 2013; 62: 581\u20136."},{"key":"10.3238\/arztebl.2014.0577_ref3","doi-asserted-by":"crossref","unstructured":"Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST: The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2011; 55: 988\u201397.","DOI":"10.1002\/hep.25505"},{"key":"10.3238\/arztebl.2014.0577_ref4","doi-asserted-by":"crossref","unstructured":"Al-Shukri I, Davidson E, Tan A, et al.: Rash and arthralgia caused by hepatitis E. Lancet 2013; 382: 1856.","DOI":"10.1016\/S0140-6736(13)62074-7"},{"key":"10.3238\/arztebl.2014.0577_ref5","doi-asserted-by":"crossref","unstructured":"van den Berg B, Annemick A, Van der Eijk A, et al.: Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection. Neurology 2014; epub ahead of print.","DOI":"10.1212\/WNL.0000000000000111"},{"key":"10.3238\/arztebl.2014.0577_ref6","doi-asserted-by":"crossref","unstructured":"Pischke S, Heim A, Bremer B, et al.: Hepatitis E: An emerging infectious disease in Germany? Z Gastroenterol 2011; 49: 1255\u20137.","DOI":"10.1055\/s-0031-1273394"},{"key":"10.3238\/arztebl.2014.0577_ref7","doi-asserted-by":"crossref","unstructured":"Wichmann O, Schimanski S, Koch J, et al.: Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198: 1732\u201341.","DOI":"10.1086\/593211"},{"key":"10.3238\/arztebl.2014.0577_ref8","doi-asserted-by":"crossref","unstructured":"Hewitt PE, Ijaz S, Brailsford SR, et al.: Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; epub ahead of print.","DOI":"10.1016\/S0140-6736(14)61034-5"},{"key":"10.3238\/arztebl.2014.0577_ref9","doi-asserted-by":"crossref","unstructured":"Arbeitskreis Blut, Untergruppe \u201eBewertung blutassoziierter Krankheitserreger\u201c: Hepatitis E Virus. Transfus Med Hemother 2009; 36: 40\u20137.","DOI":"10.1159\/000197321"},{"key":"10.3238\/arztebl.2014.0577_ref10","doi-asserted-by":"crossref","unstructured":"Faber MS, Wenzel JJ, Jilg W, et al.: Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis 2012; 18: 1654\u20137.","DOI":"10.3201\/eid1810.111756"},{"key":"10.3238\/arztebl.2014.0577_ref11","doi-asserted-by":"crossref","unstructured":"Christensen PB, Engle RE, Hjort C, et al.: Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008; 47: 1026\u201331.","DOI":"10.1086\/591970"},{"key":"10.3238\/arztebl.2014.0577_ref12","doi-asserted-by":"crossref","unstructured":"Ijaz S, Vyse AJ, Morgan D, et al.: Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44: 272\u20136.","DOI":"10.1016\/j.jcv.2009.01.005"},{"key":"10.3238\/arztebl.2014.0577_ref13","doi-asserted-by":"crossref","unstructured":"Said B, Ijaz S, Kafatos G, et al.: Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15: 1738\u201344.","DOI":"10.3201\/eid1511.091094"},{"key":"10.3238\/arztebl.2014.0577_ref14","doi-asserted-by":"crossref","unstructured":"Zhu FC, Zhang J, Zhang XF, et al.: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895\u2013902.","DOI":"10.1016\/S0140-6736(10)61030-6"},{"key":"10.3238\/arztebl.2014.0577_ref15","doi-asserted-by":"crossref","unstructured":"Pischke S, Hardtke S, Bode U, et al.: Ribavirin treatment of acute and chronic hepatitis E: a single center experience. Liver International 2013; 33: 722\u20136.","DOI":"10.1111\/liv.12114"},{"key":"10.3238\/arztebl.2014.0577_ref16","doi-asserted-by":"crossref","unstructured":"Kamar N, Izopet J, Tripon S, et al.: Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370: 1111\u201320.","DOI":"10.1056\/NEJMoa1215246"},{"key":"10.3238\/arztebl.2014.0577_ref17","doi-asserted-by":"crossref","unstructured":"Bose PD, Das BC, Kumar A, et al.: High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. J Hepatol 2011; 54: 1107\u201313.","DOI":"10.1016\/j.jhep.2010.08.037"},{"key":"10.3238\/arztebl.2014.0577_ref18","doi-asserted-by":"crossref","unstructured":"Baruah B, Bose PD, Ray C, et al.: Role of genetic alteration in MTHFR gene and homo-cysteine levles as critical factors influenceing HEV related pregnancy outcome. Journal of Hepatology 2012; 56: 32\u20133.","DOI":"10.1016\/S0168-8278(12)60088-9"},{"key":"10.3238\/arztebl.2014.0577_ref19","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez Tall\u00f3n AI, Moreira Vicente V, Mateos Lindemann ML, Ach\u00e9car Justo LM: Chronic hepatitis E in an immunocompetent patient. Gastroenterol Hepatol 2011; 34: 398\u2013400.","DOI":"10.1016\/j.gastrohep.2011.02.011"},{"key":"10.3238\/arztebl.2014.0577_ref20","doi-asserted-by":"crossref","unstructured":"Kamar N, Selves J, Mansuy JM, et al.: Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811\u20137.","DOI":"10.1056\/NEJMoa0706992"},{"key":"10.3238\/arztebl.2014.0577_ref21","doi-asserted-by":"crossref","unstructured":"Suneetha PV, Pischke S, Schlaphoff V, et al.: Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55: 695\u2013708.","DOI":"10.1002\/hep.24738"},{"key":"10.3238\/arztebl.2014.0577_ref22","doi-asserted-by":"crossref","unstructured":"Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J: How should hepatitis e virus infection be defined in organ-transplant recipients? Am J Transplant 2013; 13: 1935\u20136.","DOI":"10.1111\/ajt.12253"},{"key":"10.3238\/arztebl.2014.0577_ref23","doi-asserted-by":"crossref","unstructured":"Kamar N, Garrouste C, Haagsma EB, et al.: Factors associated with chronic hepatitis in patients with hepatitis e virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481\u20139.","DOI":"10.1053\/j.gastro.2011.02.050"},{"key":"10.3238\/arztebl.2014.0577_ref24","doi-asserted-by":"crossref","unstructured":"Pischke S, Stiefel P, Franz B, et al.: Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12: 3128\u201333.","DOI":"10.1111\/j.1600-6143.2012.04200.x"},{"key":"10.3238\/arztebl.2014.0577_ref25","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhou X, Debing Y, et al.: Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014; 146: 1775\u201383.","DOI":"10.1053\/j.gastro.2014.02.036"},{"key":"10.3238\/arztebl.2014.0577_ref26","doi-asserted-by":"crossref","unstructured":"Zhou X, Wang Y, Metselaar HJ, et al.: Rapamycin and everolimus facilitate hepatitis E virus replication: Revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. Journal of Hepatology 2014; epub ahead of print.","DOI":"10.1016\/j.jhep.2014.05.026"},{"key":"10.3238\/arztebl.2014.0577_ref27","doi-asserted-by":"crossref","unstructured":"Pischke S, Suneetha PV, Baechlein C, et al.: Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16: 74\u201382.","DOI":"10.1002\/lt.21958"},{"key":"10.3238\/arztebl.2014.0577_ref28","doi-asserted-by":"crossref","unstructured":"Haagsma EB, Niesters HG, van den Berg AP, et al.: Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15: 1225\u20138.","DOI":"10.1002\/lt.21819"},{"key":"10.3238\/arztebl.2014.0577_ref29","doi-asserted-by":"crossref","unstructured":"Pas SD, de Man RA, Mulders C, et al.: Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012; 18: 869\u201372.","DOI":"10.3201\/eid1805.111712"},{"key":"10.3238\/arztebl.2014.0577_ref30","doi-asserted-by":"crossref","unstructured":"Geng Y, Zhang H, Huang W, et al.: Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon 2014; 14: e15618.","DOI":"10.5812\/hepatmon.15618"},{"key":"10.3238\/arztebl.2014.0577_ref31","doi-asserted-by":"crossref","unstructured":"Feldt T, Sarfo FS, Zoufaly A, et al.: Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol 2013; 58: 18\u201323.","DOI":"10.1016\/j.jcv.2013.05.004"},{"key":"10.3238\/arztebl.2014.0577_ref32","doi-asserted-by":"crossref","unstructured":"Naik A, Gupta N, Goel D, et al.: Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 2013; 20: e138\u201340.","DOI":"10.1111\/jvh.12027"},{"key":"10.3238\/arztebl.2014.0577_ref33","doi-asserted-by":"crossref","unstructured":"Pischke S, Gisa A, Suneetha PV, et al.: Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One 2014; 9: e85330.","DOI":"10.1371\/journal.pone.0085330"},{"key":"10.3238\/arztebl.2014.0577_ref34","doi-asserted-by":"crossref","unstructured":"Junge N, Pischke S, Baumann U, et al.: Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 2013; 17: 343\u20137.","DOI":"10.1111\/petr.12077"},{"key":"10.3238\/arztebl.2014.0577_ref35","doi-asserted-by":"crossref","unstructured":"Baylis SA, Blumel J, Mizusawa S, et al.: World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013; 19: 729\u201335.","DOI":"10.3201\/eid1905.121845"},{"key":"10.3238\/arztebl.2014.0577_ref36","doi-asserted-by":"crossref","unstructured":"Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W: Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207: 497\u2013500.","DOI":"10.1093\/infdis\/jis688"},{"key":"10.3238\/arztebl.2014.0577_ref37","doi-asserted-by":"crossref","unstructured":"Schnegg A, Burgisser P, Andre C, et al.: An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. PLoS One 2013; 8: e62980.","DOI":"10.1371\/journal.pone.0062980"},{"key":"10.3238\/arztebl.2014.0577_ref38","unstructured":"Zhang J, Zhang XF, Zhou C, et al.: Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2013; epub ahead of print."},{"key":"10.3238\/arztebl.2014.0577_ref39","doi-asserted-by":"crossref","unstructured":"Wu T, Zhu FC, Huang SJ, et al.: Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2011; 55: 2038.","DOI":"10.1002\/hep.25522"},{"key":"10.3238\/arztebl.2014.0577_ref40","doi-asserted-by":"crossref","unstructured":"Emerson SU, Purcell RH: Running like water-the omnipresence of hepatitis E. N Engl J Med 2004; 351: 2367\u20138.","DOI":"10.1056\/NEJMp048285"},{"key":"10.3238\/arztebl.2014.0577_ref41","doi-asserted-by":"crossref","unstructured":"Wenzel JJ, Sichler M, Schemmerer M, et al.: Decline in hepatitis E virus antibody prevalence in Southeastern Germany, 1996\u20132011. Hepatology 2014; epub ahead of print.","DOI":"10.1055\/s-0033-1361014"},{"key":"10.3238\/arztebl.2014.0577_ref42","doi-asserted-by":"crossref","unstructured":"le Coutre P, Meisel H, Hofmann J, et al.: Reactivation of hepatitis E infection in a patient with acute lymphoplastic leucemia after allogenic stem cell transplantation. Gut 2009; 58: 699\u2013702.","DOI":"10.1136\/gut.2008.165571"},{"key":"10.3238\/arztebl.2014.0577_ref43","doi-asserted-by":"crossref","unstructured":"Versluis J, Pasch SD, Agteresch HJ, et al.: Hepatitis e virus: an underestimated, opportunistic pathogen in recipientso of allogeneic hematopoietic stem cell transplantation. Blood 2013, 122; 1079\u201386.","DOI":"10.1182\/blood-2013-03-492363"},{"key":"10.3238\/arztebl.2014.0577_ref44","doi-asserted-by":"crossref","unstructured":"Pischke S, Behrendt P, Manns MP, Wedemeyer H: HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis 2014; 8: 678\u20139.","DOI":"10.1016\/S1473-3099(14)70823-0"},{"key":"10.3238\/arztebl.2014.0577_ref45","doi-asserted-by":"crossref","unstructured":"Banks M, Bendall R, Grierson S, et al.: Human and porcine hepatitis E virus strains, United Kingdom. Emerg Infect Dis 2004; 10: 953\u20135.","DOI":"10.3201\/eid1005.030908"},{"key":"10.3238\/arztebl.2014.0577_ref46","doi-asserted-by":"crossref","unstructured":"Nelson KE: Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion 2014; 54: 8\u201310.","DOI":"10.1111\/trf.12504"},{"key":"10.3238\/arztebl.2014.0577_ref47","doi-asserted-by":"crossref","unstructured":"Halac U, Beland K, Lapierre P, et al.: Chronic hepatitis E infection in children with liver transplantation. Gut 2011; 61: 597\u2013603.","DOI":"10.1136\/gutjnl-2011-300708"},{"key":"10.3238\/arztebl.2014.0577_ref48","doi-asserted-by":"crossref","unstructured":"Teshale EH, Grytdal SP, Howard C, et al.: Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2011; 50: 1006\u201310.","DOI":"10.1086\/651077"},{"key":"10.3238\/arztebl.2014.0577_ref49","doi-asserted-by":"crossref","unstructured":"Schlosser B, Stein A, Neuhaus R, et al.: Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2011; 56: 500\u20132.","DOI":"10.1016\/j.jhep.2011.06.021"},{"key":"10.3238\/arztebl.2014.0577_ref50","doi-asserted-by":"crossref","unstructured":"van Eijk JJ, Madden RG, van der Eijk AA, et al.: Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014; 82: 498\u2013503.","DOI":"10.1212\/WNL.0000000000000112"},{"key":"10.3238\/arztebl.2014.0577_ref51","doi-asserted-by":"crossref","unstructured":"Kamar N, Weclawiak H, Guilbeau-Frugier C, et al.: Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93: 617\u201323.","DOI":"10.1097\/TP.0b013e318245f14c"},{"key":"10.3238\/arztebl.2014.0577_ref52","doi-asserted-by":"crossref","unstructured":"Kamar N, Bendall RP, Peron JM, et al.: Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173\u20139.","DOI":"10.3201\/eid1702.100856"},{"key":"10.3238\/arztebl.2014.0577_ref53","doi-asserted-by":"crossref","unstructured":"Pischke S, Ho H, Urbanek F, et al.: Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 2010; 17: 598\u20139.","DOI":"10.1111\/j.1365-2893.2009.01219.x"},{"key":"10.3238\/arztebl.2014.0577_ref54","doi-asserted-by":"crossref","unstructured":"Wenzel JJ, Preiss J, Schemmerer M, et al.: Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol 2011; 52: 50\u20134.","DOI":"10.1016\/j.jcv.2011.06.006"},{"key":"10.3238\/arztebl.2014.0577_ref55","doi-asserted-by":"crossref","unstructured":"Krumbholz A, Mohn U, Lange J, et al.: Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol 2011; 201: 239\u201344.","DOI":"10.1007\/s00430-011-0210-5"},{"key":"10.3238\/arztebl.2014.0577_ref56","doi-asserted-by":"crossref","unstructured":"Baylis SA, Koc O, Nick S, Blumel J: Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2011; 102: 182\u20133.","DOI":"10.1111\/j.1423-0410.2011.01527.x"},{"key":"10.3238\/arztebl.2014.0577_ref57","doi-asserted-by":"crossref","unstructured":"Pischke S, Horn-Wichmann R, Ernst D, et al.: Absence of chronic hepatitis E in a German cohort of common variable immunodeficiency patients. Infect Dis Rep 2012; 4: e28.","DOI":"10.4081\/idr.2012.e28"},{"key":"10.3238\/arztebl.2014.0577_ref58","doi-asserted-by":"crossref","unstructured":"Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J: Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012; 103: 89\u201390.","DOI":"10.1111\/j.1423-0410.2011.01583.x"},{"key":"10.3238\/arztebl.2014.0577_ref59","doi-asserted-by":"crossref","unstructured":"Pischke S, Greer M, Hardtke S, et al.: Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis 2014; 16: 333\u20139.","DOI":"10.1111\/tid.12183"},{"key":"10.3238\/arztebl.2014.0577_ref60","doi-asserted-by":"crossref","unstructured":"Krumbholz A, Joel S, Dremsek P, et al.: Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany. Med Microbiol Immunol 2014, 203: 273\u201382.","DOI":"10.1007\/s00430-014-0336-3"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:45:40Z","timestamp":1638780340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":60,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0577","relation":{"is-cited-by":[{"id-type":"doi","id":"10.5812\/hepatmon.14039","asserted-by":"object"},{"id-type":"doi","id":"10.1155\/2017\/1073253","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/s00430-017-0503-4","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}